| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:531142899:1726 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:531142899:1726?format=raw |
LEADER: 01726mam a2200385 a 4500
001 3971678
005 20221027012043.0
008 890519t19891989au a b 001 0 eng c
010 $a 89011413
020 $a0387821333 (New York)
020 $a3211821333 (Wien)
035 $a(OCoLC)ocm19814800
035 $9AGP0935HS
035 $a(NNC)3971678
035 $a3971678
040 $aDNLM/DLC$cDLC$dNNC-M
050 00 $aRC535$b.R48 1989
060 0 $aW1 JO781A no. 28$aWM 171 R452
082 0 $a616.85/27061$220
245 00 $aReversible MAO-A inhibitors as antidepressants :$bbasic advances and clinical perspectives /$cG.D. Burrows and M. Da Prada (eds.).
260 $aWien ;$aNew York :$bSpringer-Verlag,$c[1989], ©1989.
300 $a106 pages :$billustrations ;$c29 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aJournal of neural transmission. Supplementum ;$v28
504 $aIncludes bibliographical references and index.
650 0 $aDepression, Mental$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh87002383
650 0 $aMoclobemide.$0http://id.loc.gov/authorities/subjects/sh87007396
650 0 $aMonoamine oxidase$xInhibitors$xTherapeutic use.
650 2 $aDepressive Disorder$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D003866Q000188
650 2 $aMonoamine Oxidase Inhibitors$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D008996Q000627
700 1 $aBurrows, Graham D.$0http://id.loc.gov/authorities/names/n77000563
700 1 $aDa Prada, M.$0http://id.loc.gov/authorities/names/n79108640
830 0 $aJournal of neural transmission.$pSupplementum ;$v28.$0http://id.loc.gov/authorities/names/n83703013
852 80 $boff,hsr$hSerial$iJ